Overview

Genetically Informed Smoking Cessation Trial

Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
The investigators' goal is to identify the most appropriate smoking cessation treatments for smokers based on genetic information. Smokers try to quit smoking but relapses are common.
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Treatments:
Nicotine
Varenicline